Cardiología clínica

Portada
Elsevier España, 2002 - 1037 pàgines
10 Ressenyes
 

Què opinen els usuaris - Escriviu una ressenya

No hem trobat cap ressenya als llocs habituals.

Frases i termes més freqüents

Passatges populars

Pàgina 68 - Sacks FM, Pfeffer MA, Moye LA et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels.
Pàgina 148 - A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).
Pàgina 68 - The Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S).
Pàgina 411 - Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation).
Pàgina 298 - Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial.
Pàgina 298 - ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.
Pàgina 265 - Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III...
Pàgina 68 - Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.
Pàgina 451 - Buxton AE, Lee KL, Fisher JD, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease.
Pàgina 343 - Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus ; results of the HOPE study and MICRO-HOPE substudy. Lancet, 355 : 253-9, 2000.

Informació bibliogràfica